Drug interactions
Chlorambucil + Tisagenlecleucel
Severity: Major
Chlorambucil and Tisagenlecleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Chlorambucil's lymphotoxic and myelosuppressive effects may reduce the expansion and persistence of CAR T cells. It also increases the risk of infection in patients already immunocompromised after CAR T therapy.
What this interaction means in plain words
Chlorambucil and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Chlorambucil belongs to Oncology; Tisagenlecleucel belongs to Oncology.
Why it happens
Cytotoxic lymphodepletion may reduce CAR T-cell expansion and adds to additive immunosuppression.
What to do
Stop chlorambucil well before leukapheresis and do not give it around the time of infusion unless the treating team specifically directs it. Monitor for infections and cytopenias.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Chlorambucil and Tisagenlecleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Chlorambucil
Other interactions of Tisagenlecleucel
Frequently asked questions
Can I take Chlorambucil with Tisagenlecleucel?
MediHelp rates the interaction as major. Chlorambucil and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Chlorambucil's lymphotoxic and myelosuppressive effects may reduce the expansion and persistence of CAR T cells. It also increases the risk of infection in patients already immunocompromised after CAR T therapy.
How serious is the interaction between Chlorambucil and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop chlorambucil well before leukapheresis and do not give it around the time of infusion unless the treating team specifically directs it. Monitor for infections and cytopenias.
What other medicines interact with Chlorambucil?
MediHelp also lists interactions of Chlorambucil with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Chlorambucil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
